2018
DOI: 10.1039/c7nj03973e
|View full text |Cite
|
Sign up to set email alerts
|

Hybrid bacterial cellulose–pectin films for delivery of bioactive molecules

Abstract: Novel biopolymeric films based on bacterial cellulose (BC) modified with high methoxylated pectin (HMP) were developed for drug delivery.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
18
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 46 publications
(21 citation statements)
references
References 47 publications
3
18
0
Order By: Relevance
“…Most dermal patches are prepared by simply soaking a pure BC membrane, or a BC‐based composite, in a solution of the compounds of interest. In order to achieve multiple desired results, these membranes can be loaded with more than one compound at once.…”
Section: Applicationsmentioning
confidence: 99%
See 1 more Smart Citation
“…Most dermal patches are prepared by simply soaking a pure BC membrane, or a BC‐based composite, in a solution of the compounds of interest. In order to achieve multiple desired results, these membranes can be loaded with more than one compound at once.…”
Section: Applicationsmentioning
confidence: 99%
“…Furthermore, the drug loading capacity and drug release rate were further controlled by the drying method of the membranes (freeze drying vs. oven drying). In another study, two different molecules were loaded in a BC‐based composite, specifically serum albumin, which modulated the release of the other molecule, levofloxacin, reducing its cytotoxicity to undetected levels, without losing its antibacterial activity. These three mentioned studies, are a great example of the versatility of BC to further develop dermal patches for drug delivery systems, that can be laden with different molecules while maintaining properties of interest.…”
Section: Applicationsmentioning
confidence: 99%
“…an exopolysaccharide produced by some non-pathogenic bacteria, namely the acetic acid bacteria of the genus Komagataeibacter (formerly classified as Gluconacetobacter) [17,18], is gaining increasing attention in the biomedical realm [19][20][21], particularly as a wound-dressing material [19,22,23]. Hence, the current study was inspired not only by the biocompatibility, high water-retention capacity, nanostructured porous network and good in vivo skin compatibility of BNC [20,24], but also by the fact that this exopolysaccharide can be directly produced in the form of membranes or films with customizable size and shape, and can house an array of active molecules (e.g., lidocaine [25,26], diclofenac [27,28], amoxicillin [29] and levofloxacin [30]) and macromolecules (e.g., poly([2-(methacryloyloxy)ethyl]trimethylammonium chloride) [31] and vitamin B-based ionic liquids [32]) that confer new functionalities to the ensuing materials. Although (i) HA has already been added to the culture media during BNC biosynthesis, to obtain BNC/HA membranes with no specific application [33], and (ii) the combination between BNC and DCF has already been studied for transdermal delivery [27], the coalition of BNC with HA and DCF has not yet been studied, at least to the best of our knowledge, for the potential treatment of aphthous stomatitis.…”
Section: Introductionmentioning
confidence: 99%
“…For instance, neat BNC membranes have already been combined with drugs and other bioactive compounds, such as lidocaine [22,23], ibuprofen [23], caffeine [24], diclofenac [25] and amoxicillin [26] in their most common forms or formulated as ionic liquids [27,28] for cutaneous drug delivery. There are also examples of BNC-based nanocomposites being used for the cutaneous delivery of diclofenac [29] and BNC-based hybrid films for the cutaneous delivery of levofloxacin [30].…”
Section: Introductionmentioning
confidence: 99%